| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/17/2011 | CA2771055A1 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 02/17/2011 | CA2770724A1 Compounds and methods of use thereof |
| 02/17/2011 | CA2770698A1 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions |
| 02/17/2011 | CA2770441A1 Sigma ligands for the prevention or treatment of pain induced by chemotherapy |
| 02/17/2011 | CA2770211A1 Methods for iontophoretically treating nausea and migraine |
| 02/17/2011 | CA2769820A1 Method for making 3.alpha.-hydroxy, 3.beta.- methyl-5.alpha.-pregnan-20-one (ganaxolone) |
| 02/17/2011 | CA2768749A1 Inhibitors of jnk |
| 02/17/2011 | CA2765265A1 Method for repairing neurodegeneration |
| 02/17/2011 | CA2760516A1 Pyrido[4,3-b]indoles and methods of use |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2284171A1 Amides of diazabicycloalkanes selective for nicotinic acetylcholine receptor sub-types |
| 02/16/2011 | EP2284170A1 Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/16/2011 | EP2284169A1 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of CNS disorders |
| 02/16/2011 | EP2284160A1 Pyrimidine derivative having cell-protecting activity and use thereof |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283860A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/16/2011 | EP2283858A2 West Nile Vaccine |
| 02/16/2011 | EP2283842A1 Tamper-resitant oral opioid agonist formulations |
| 02/16/2011 | EP2283841A1 Selective serotonin receptor inverse agonists as therapeutics for disease |
| 02/16/2011 | EP2283840A1 The use of mirtazapine for the treatment of sleep disorders. |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283834A2 Therapeutic compositions comprising ketone bodies or their precursors |
| 02/16/2011 | EP2283833A2 Amines and amides for the treatment of diseases |
| 02/16/2011 | EP2283829A1 Controlled release hydrocodone formulations |
| 02/16/2011 | EP2283024A1 4-aryl-2-anilino-pyrimidines as plk kinase inhibitors |
| 02/16/2011 | EP2283023A2 Bryostatin analogues and methods of making and using thereof |
| 02/16/2011 | EP2283022A1 Furo ý3, 2-b¨pyrr0l-3-0nes as cathepsin s inhibitors |
| 02/16/2011 | EP2283016A1 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 02/16/2011 | EP2283008A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283007A2 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 02/16/2011 | EP2283000A2 3- or 4-substituted piperidine compounds |
| 02/16/2011 | EP2282999A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
| 02/16/2011 | EP2282815A1 Role of (de)acetylation in counteracting protein aggregation |
| 02/16/2011 | EP2282781A1 Methods for radiolabelling synthetic polymers |
| 02/16/2011 | EP2282779A1 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response |
| 02/16/2011 | EP2282778A2 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis |
| 02/16/2011 | EP2282766A1 Suture line administration technique using botulinum toxins |
| 02/16/2011 | EP2282758A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
| 02/16/2011 | EP2282751A1 Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect |
| 02/16/2011 | EP2282748A2 Treatment of brain damage using umbilical cord blood cells |
| 02/16/2011 | EP2282747A1 Use of enteric glia |
| 02/16/2011 | EP2282738A2 Promoting axon regeneration in the adult cns through control of protein translation |
| 02/16/2011 | EP2282735A1 Compounds, compositions and methods for making the same |
| 02/16/2011 | EP2282721A2 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant |
| 02/16/2011 | EP2155729B1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists |
| 02/16/2011 | EP2010518B1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors |
| 02/16/2011 | EP1771422B1 Quinazolinone derivatives as parp inhibitors |
| 02/16/2011 | EP1599211B1 Use isoharmnetin for treating depressive states and depression |
| 02/16/2011 | EP1466178B1 Screening methods for superoxide dismutase (sod)-inhibitors |
| 02/16/2011 | EP1455794B1 ClC-2 CHANNEL OPENER FOR TREATING GASTRIC OR BOWEL ULCER |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | EP1379498B1 Sulphones which modulate the action of gamma secretase |
| 02/16/2011 | EP1222265B1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 02/16/2011 | CN201743369U Multifunction pillow |
| 02/16/2011 | CN1989113B Quinazoline derivatives |
| 02/16/2011 | CN1935191B External ointment for treating facioplegia and its production method |
| 02/16/2011 | CN1931251B Analgesic medicine composition and its preparation process and application |
| 02/16/2011 | CN1919273B Chinese medicinal composition for treating headache |
| 02/16/2011 | CN1850804B Optical-purity meptazinol orits salts, and preparing method |
| 02/16/2011 | CN1846456B Communication system for wireless microphone |
| 02/16/2011 | CN1660398B Combination of medication for treating sleep disorder |
| 02/16/2011 | CN101977907A Pyrrolidinyl derivatives and uses thereof |
| 02/16/2011 | CN101977904A Aminopiperidinyl derivatives and uses thereof |
| 02/16/2011 | CN101977903A Preparation of sulfamide derivatives |
| 02/16/2011 | CN101977655A Indazole derivatives |
| 02/16/2011 | CN101977613A Synergistic 5'-methylthioadenosine combinations |
| 02/16/2011 | CN101977606A Methods for treating disorders using nmda nr2b-subtype selective antagonist |
| 02/16/2011 | CN101977594A Method for the identification of patients in need of therapy having minor cognitive disorders and the treatment of such patients |
| 02/16/2011 | CN101974487A Method for preparing neural stem cells with highest migration efficiency and application thereof |
| 02/16/2011 | CN101974485A Method for preparing mesenchymal stem cells with optimum transfer ability and application thereof |
| 02/16/2011 | CN101974392A Preparation method of ginseng flower active liquor |
| 02/16/2011 | CN101974390A Anti-ageing Chinese medicament healthcare wine and preparation method thereof |
| 02/16/2011 | CN101974089A Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection |
| 02/16/2011 | CN101974046A New natural antipodal kaurane derivative and preparation method and application thereof |
| 02/16/2011 | CN101972471A Application of Ulinastatin in preparing drug for curing autoimmune encephalomyelitis and pharmaceutical composition thereof |
| 02/16/2011 | CN101972462A Alcohol-relieving healthcare product |
| 02/16/2011 | CN101972455A Medicament for treating vascular headache and preparation method thereof |
| 02/16/2011 | CN101972452A Medicament for treating cerebral trauma associated tardive cranial nerve dysfunction |
| 02/16/2011 | CN101972439A Traditional Chinese medicine for treating diabetic foot |
| 02/16/2011 | CN101972414A Method for establishing single-gastrodia capsule fingerprint and fingerprint thereof |
| 02/16/2011 | CN101972412A Composition of tall gastrodia tuber and lecithin, and preparation method thereof |
| 02/16/2011 | CN101972403A Medicinal liquor for treating white hair |
| 02/16/2011 | CN101972395A Calming and decompressing traditional Chinese medicine composition and preparation method thereof |
| 02/16/2011 | CN101972371A Medicament for treating hemicrania and preparation method thereof |
| 02/16/2011 | CN101972370A Chinese medicinal preparation for treating persistent vegetative state (PVS) |
| 02/16/2011 | CN101972367A Traditional Chinese medicine for treating diabetic peripheral neuropathy |
| 02/16/2011 | CN101972332A Traditional Chinese medicine for treating palpitations |
| 02/16/2011 | CN101972326A Medicinal preparation for relieving alcohol toxin |
| 02/16/2011 | CN101972315A Traditional Chinese medicinal composition and preparation method and use thereof |
| 02/16/2011 | CN101972310A Anti-anxiety medicine by using rheum officinate root extract as active ingredient, and method and application thereof |
| 02/16/2011 | CN101972296A External traditional Chinese medicine for treating facial paralysis |
| 02/16/2011 | CN101972294A New usage of eucommia ulmoides chemical composition as vessel protective agent |
| 02/16/2011 | CN101972259A Brucine and application of derivatives thereof in preparation of drugs for treating alcoholic abuse and dependence |
| 02/16/2011 | CN101972256A Smoking cessation chewing gum capable of protecting oral mucosa |
| 02/16/2011 | CN101972252A Application of Tetrahydroberbeine berberrubine in preparing drug for resisting anxiety and depression |
| 02/16/2011 | CN101972251A Use of hirsutine in preparing anti-addictive drug |
| 02/16/2011 | CN101972243A Application of puerarin to preparing medicine for treating P2X3 receptor mediated nerve system disease |
| 02/16/2011 | CN101972242A Application of puerarin in preparation of drugs for treating P2X3 receptor-mediated acute pain |